Clinical Social Workers in Towaco, NJ Accepting Medicare
2 Clinical Social Workers found. Showing 1 - 2
 Ms. Michelle Bauer, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 Turner Ln, Towaco, NJ 07082 Phone: 973-257-2812 Fax: 973-257-2812 |
Nancy Charlene Morris, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 Heritage Ct, Towaco, NJ 07082 Phone: 973-900-4650 |
News Archive
Prebiotic Inulin fiber supplement from Standard Process
Our gut is home to different types of bacteria, many of which live in harmony with us. Maintaining a balance of helpful bacteria within the gut is important for the health of several body functions. To help provide a favorable environment for friendly microbes to thrive, Standard Process Inc.® proudly introduces its newest product, Prebiotic Inulin.
California stimulus funding not enough to stave off cuts to some health care services
California Gov. Arnold Schwarzenegger (R) on Friday signed five bills into law that allow California to receive more than $17.5 billion in federal economic stimulus aid, but the funding will not be enough for the state to avoid $3 billion in tax increases and cuts to services to balance its budget, the San Francisco Chronicle reports.
Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A
Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.
Turing Pharmaceuticals acquires rights to market Daraprim (pyrimethamine) in the U.S.
Turing Pharmaceuticals AG today announced that it has acquired the exclusive rights to market Daraprim (pyrimethamine) in the U.S. from Impax Laboratories, Inc. The acquisition by Turing is part of a strategic effort focused on treatments for toxoplasmosis and other serious infectious diseases. The company also announced plans to invest in the development of new drug candidates for toxoplasmosis.
European Investment Bank supports Bavarian Nordic's development of Ebola and cancer vaccines
The European Investment Bank (EIB), the world's largest multilateral bank, today reaffirmed its firm commitment to respond to the Ebola pandemic. The Bank has provided a EUR 50 million loan to Bavarian Nordic, an international biopharmaceutical company, for accelerated development of an Ebola vaccine with long-term efficacy. The financing is also backing research into vaccines for treating other infectious diseases and multiple cancer indications.
› Verified 5 days ago